Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;74:1424-1433

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ambrosio, G.
Right arrow Articles by Weisfeldt, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ambrosio, G.
Right arrow Articles by Weisfeldt, M. L.

Circulation, Vol 74, 1424-1433, Copyright © 1986 by American Heart Association


ARTICLES

Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury

G Ambrosio, LC Becker, GM Hutchins, HF Weisman and ML Weisfeldt

To determine the importance of reperfusion injury and the ability of the free-radical scavenger recombinant human superoxide dismutase (h- SOD) to prevent it, open-chest dogs underwent 90 min of proximal circumflex coronary artery occlusion, and only at the moment of reperfusion received either h-SOD (400,000 IU bolus into the left atrium followed by a 300,000 IU iv infusion over 1 hr) or saline. After 48 hr the surviving animals were killed and measurements were made of the risk region (by postmortem angiography) and infarct size (by gross pathology). All measurements were made by investigators blinded to treatment given, and the code was broken only at the end of the study. Hemodynamic variables and collateral flow during ischemia were similar in the two groups. Infarct size in control animals (n = 8) averaged 22.4 +/- 3.1% of the left ventricle and 52.2 +/- 7.1% of the risk region, compared with 13.3 +/- 0.8% of the left ventricle and 33.6 +/- 2.1% of the risk region in h-SOD-treated dogs (n = 8) (p less than .05). Infarcts in treated animals were not only smaller, but also exhibited a distinctive "patchiness," suggesting protection along vascular distributions. Furthermore, analysis of the relationship between infarct size and collateral flow measured during ischemia in the two groups indicated that protection by h-SOD was greatest in animals with the lowest collateral flows. This study supports the concept that reperfusion of ischemic myocardium results in a separate component of cell damage, presumably linked to the generation of oxygen free radicals on reflow. Since the h-SOD preventable reperfusion component of injury was most pronounced in hearts with the most severe ischemia, scavenging of oxygen radicals at the time of reflow may offer a novel and particularly promising therapeutic approach for the protection of ischemic myocardium.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. Murphy and C. Steenbergen
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Physiol Rev, April 1, 2008; 88(2): 581 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Fukushima, S. R. Coppen, A. Varela-Carver, G. Brindley, K. Yamahara, P. Sarathchandra, M. H. Yacoub, and K. Suzuki
Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration
Cardiovasc Res, February 1, 2006; 69(2): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Shimada, Y Sakanoue, Y Kobayashi, S Ehara, M Hirose, Y Nakamura, D Fukuda, H Yamagishi, M Yoshiyama, K Takeuchi, et al.
Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction
Heart, January 1, 2003; 89(1): 71 - 76.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, M. R. Hoffmeyer, B. R. Sharp, Y.-S. Ho, and D. J. Lefer
Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H277 - H282.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. R. Lucchesi
Looking Toward the Future, Using Lessons from the Past
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 829 - 836.
[Abstract] [Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Martin, G. Lutter, K. Sarai, M. Senn-Grossberger, N. Takahashi, J. Bitu-Moreno, J. Haberstroh, and F. Beyersdorf
Investigations on the new free radical scavenger polynitroxyl-albumin to prevent ischemia and reperfusion injury after orthotopic heart transplantation in the pig model
Eur. J. Cardiothorac. Surg., March 1, 2001; 19(3): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. R. Hoffmeyer, S. P. Jones, C. R. Ross, B. Sharp, M. B. Grisham, F. S. Laroux, T. J. Stalker, R. Scalia, and D. J. Lefer
Myocardial Ischemia/Reperfusion Injury in NADPH Oxidase-Deficient Mice
Circ. Res., October 27, 2000; 87(9): 812 - 817.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Weman, P. J. Karhunen, A. Penttila, A. A. Jarvinen, and U.-S. Salminen
Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting
Ann. Thorac. Surg., September 1, 2000; 70(3): 807 - 812.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Gurlek, E. Tutar, E. Akcil, I. Dincer, C. Erol, P. A. Kocaturk, and D. Oral
The effects of L-carnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy
Eur J Heart Fail, June 1, 2000; 2(2): 189 - 193.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Suzuki, Y. Sawa, H. Ichikawa, Y. Kaneda, and H. Matsuda
Myocardial protection with endogenous overexpression of manganese superoxide dismutase
Ann. Thorac. Surg., October 1, 1999; 68(4): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Grund, H. T. Sommerschild, T. Lyberg, K. A. Kirkeboen, and A. Ilebekk
Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H533 - H542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Becker, R. W. Jeremy, J. Schaper, and W. Schaper
Ultrastructural assessment of myocardial necrosis occurring during ischemia and 3-h reperfusion in the dog
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H243 - H252.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Bowes, M. C. McDonald, J. Piper, and C. Thiemermann
Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress
Cardiovasc Res, January 1, 1999; 41(1): 126 - 134.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Matetzky, D. Freimark, P. Chouraqui, I. Novikov, O. Agranat, B. Rabinowitz, E. Kaplinsky, and H. Hod
The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1326 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. A. Garcia, S. C. DeJong, S. M. Martin, R. S. Smith, G. R. Buettner, and R. E. Kerber
Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model
J. Am. Coll. Cardiol., August 1, 1998; 32(2): 536 - 539.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, H. Chen, H. Qin, S. Sankarapandi, M. W. Becher, P. C. Wong, and J. L. Zweier
Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury
PNAS, April 14, 1998; 95(8): 4556 - 4560.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Matsumura, R. W. Jeremy, J. Schaper, and L. C. Becker
Progression of Myocardial Necrosis During Reperfusion of Ischemic Myocardium
Circulation, March 3, 1998; 97(8): 795 - 804.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. O. Nossuli, R. Hayward, R. Scalia, and A. M. Lefer
Peroxynitrite Reduces Myocardial Infarct Size and Preserves Coronary Endothelium After Ischemia and Reperfusion in Cats
Circulation, October 7, 1997; 96(7): 2317 - 2324.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Yanagida, C.S. Luo, M. Doyle, G.M. Pohost, and M.M. Pike
Nuclear Magnetic Resonance Studies of Cationic and Energetic Alterations With Oxidant Stress in the Perfused Heart : Modulation With Pyruvate and Lactate
Circ. Res., October 1, 1995; 77(4): 773 - 783.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Xia and J. L. Zweier
Substrate Control of Free Radical Generation from Xanthine Oxidase in the Postischemic Heart
J. Biol. Chem., August 11, 1995; 270(32): 18797 - 18803.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Ohnishi, M. C. Butterfield, J. E. Saffitz, B. E. Sobel, P. B. Corr, and J. A. Goldstein
Deleterious Effects of a Systemic Lytic State on Reperfused Myocardium : Minimization of Reperfusion Injury and Enhanced Recovery of Myocardial Function by Direct Angioplasty
Circulation, August 1, 1995; 92(3): 500 - 510.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Zahger, J. Yano, A. Chaux, M. C. Fishbein, and W. Ganz
Absence of Lethal Reperfusion Injury After 3 Hours of Reperfusion : A Study in a Single-Canine-Heart Model of Ischemia-Reperfusion
Circulation, June 15, 1995; 91(12): 2989 - 2994.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. F. Seccombe, P. J. Pearson, and H. V. Schaff
Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 505 - 509.
[Abstract] [Full Text]


Home page
PerfusionHome page
C. Munsch
Review article : Blood cardioplegia
Perfusion, October 1, 1991; 6(4): 245 - 252.
[PDF]


Home page
Arch SurgHome page
A. A. Rodriguez, W. W. LaMorte, L. M. Hanrahan, S. R. Hopkins, J. C. O'Keane, R. Cachecho, and E. F. Hirsch
Liver Viability After Ischemia-Reperfusion
Arch Surg, June 1, 1991; 126(6): 767 - 772.
[Abstract] [PDF]


Home page
Arch SurgHome page
B. A. Zikria, C. Subbarao, M. C. Oz, S. J. Popilkis, R. Sachdev, P. Chauhan, H. P. Freeman, and T. C. King
Hydroxyethyl Starch Macromolecules Reduce Myocardial Reperfusion Injury
Arch Surg, July 1, 1990; 125(7): 930 - 934.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. V. Cohen
Free Radicals in Ischemic and Reperfusion Myocardial Injury: Is this the Time for Clinical Trials?
Ann Intern Med, December 1, 1989; 111(11): 918 - 931.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Reffelmann, S. L. Hale, G. Li, and R. A. Kloner
Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H766 - H772.
[Abstract] [Full Text] [PDF]